SINOVAC BIOTECH LTD
Datakwaliteit: 100%
SVA
NASDAQ
Manufacturing
Chemicals
€ 6,47
€ 0,00
(0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
16,18%
Groei
Revenue Growth (5Y)
16,18%
Boven sectorgemiddelde (1,72%)
Revenue (1Y)-69,97%
Earnings (1Y)-187,75%
FCF Growth (3Y)-91,57%
Kwaliteit
Return on Equity
-1,13%
Boven sectorgemiddelde (-54,68%)
ROIC-3,73%
Net Margin-22,29%
Op. Margin-134,52%
Veiligheid
Debt / Equity
0,03
Onder sectorgemiddelde (0,30)
Current Ratio10,31
Interest Coverage-266,82
Waardering
PE (TTM)
-6,43
Onder sectorgemiddelde (-1,49)
P/B Ratio0,07
EV/EBITDAN/A
Dividend Yield850,08%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 16,18% annually over 5 years — strong growth
Earnings declined -187,75% over the past year
Debt/Equity of 0,03 — conservative balance sheet
Generating 104,00 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 86,15%
Dividend yield of 850,08% — meaningful income
Price History
Financiële Trends
Koersdoel Analisten
6 analisten
Hold
-45.6%
upside to target
Huidig
€ 6,47
Consensus Target
€ 3,52
€ 1,50
Laag
€ 6,00
Hoog
Vooruitzicht
Omzet Sch.
0,0
Winstverassingen
EPS
Reported
Estimate
| Q32023 | Q42023 | Q12024 | Q22024 | |
|---|---|---|---|---|
| Reported | -€ 0,03 | -€ 0,04 | -€ 0,03 | -€ 0,03 |
| Estimate | -€ 0,02 | -€ 0,02 | -€ 0,03 | -€ 0,03 |
| Verrassing | -50,00% | -100,00% | 0,00% | 0,00% |
Growth
Rev 5Y: 16,18% · Earnings 1Y: -187,75%
Growth
Rev 5Y: 16,18% · Earnings 1Y: -187,75%| Revenue Growth (1Y) | -69,97% | Revenue Growth (3Y) | -84,79% |
| Earnings Growth (1Y) | -187,75% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16,18% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -1,13% · Net Margin: -22,29%
Profitability
ROE: -1,13% · Net Margin: -22,29%| Revenue (TTM) | 448,27 M | Net Income (TTM) | -99,92 M |
| ROE | -1,13% | ROA | -0,72% |
| Gross Margin | 59,51% | Operating Margin | -134,52% |
| Net Margin | -22,29% | Free Cash Flow (TTM) | 104,00 M |
| ROIC | -3,73% | FCF Growth (3Y) | -91,57% |
Safety
D/E: 0,03 · Current: 10,31
Safety
D/E: 0,03 · Current: 10,31| Debt / Equity | 0,03 | Current Ratio | 10,31 |
| Interest Coverage | -266,82 | Asset Turnover | 0,03 |
| Working Capital | 10,68 B | Tangible Book Value | 8,70 B |
Dividends
Yield: 850,08% · Payout: N/A
Dividends
Yield: 850,08% · Payout: N/A| Dividend Yield | 850,08% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
Valuation
P/E: -6,43 · EV/EBITDA: N/A
Valuation
P/E: -6,43 · EV/EBITDA: N/A| P/E Ratio | -6,43 | Forward P/E | N/A |
| P/B Ratio | 0,07 | P/S Ratio | 1,43 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 16,19% | ||
| Market Cap | 642,44 M | Enterprise Value | -373,79 M |
Per Share
EPS: -1,06 · FCF/Share: 1,05
Per Share
EPS: -1,06 · FCF/Share: 1,05| EPS (Diluted TTM) | -1,06 | Revenue / Share | 4,51 |
| FCF / Share | 1,05 | OCF / Share | 1,05 |
| EPS CAGR (1Y) | -206,00% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: -104,08% · CapEx/Rev: N/A
Efficiency
FCF Conv: -104,08% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | -104,08% |
| SBC-Adj. FCF | 104,00 M | Growth Momentum | -86,15 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | 448,27 M | 1,49 B | 19,37 B | 510,62 M | 246,05 M |
| Net Income | -99,92 M | 113,87 M | 8,47 B | 110,37 M | 44,93 M |
| EPS (Diluted) | -1,06 | 1,00 | 74,27 | 0,97 | 0,41 |
| Gross Profit | 266,75 M | 808,31 M | 18,30 B | 443,44 M | 213,58 M |
| Operating Income | -603,02 M | -466,07 M | 17,55 B | 215,64 M | 68,56 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 344,52 M | 442,11 M | 155,04 M | 48,76 M | 24,25 M |
| SG&A Expenses | 466,32 M | 823,54 M | 591,17 M | 176,53 M | 121,47 M |
| D&A | — | — | — | — | — |
| Interest Expense | 2,26 M | 1,26 M | 2,84 M | 1,45 M | 650.000,0 |
| Income Tax | 105,32 M | -62,89 M | 3,10 B | 31,44 M | 5,61 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Total Assets | 13,66 B | 14,11 B | 16,75 B | 1,90 B | 452,30 M |
| Total Liabilities | 1,64 B | 1,40 B | 2,87 B | 781,20 M | 100,10 M |
| Shareholders' Equity | 8,71 B | 8,92 B | 9,33 B | 746,47 M | 294,02 M |
| Total Debt | 253,91 M | 11,81 M | 15,77 M | 35,10 M | 5,93 M |
| Cash & Equivalents | 1,27 B | 4,28 B | 11,61 B | 1,04 B | 152,72 M |
| Current Assets | 11,83 B | 12,13 B | 14,92 B | 1,56 B | 349,61 M |
| Current Liabilities | 1,15 B | 1,09 B | 2,41 B | 679,61 M | 87,20 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,4 | -1,5 |
| P/B | 0,1 | 1,6 |
| ROE % | -1,1 | -54,7 |
| Net Margin % | -22,3 | -41,5 |
| Rev Growth 5Y % | 16,2 | 1,7 |
| D/E | 0,0 | 0,3 |
Dividendgeschiedenis
Dividendgeschiedenis
Rendement
850,08%
Uitkeringsratio
N/A
Groei (3 jr)
N/A
Groei (5 jr)
N/A
Recente betalingen per aandeel (nieuwste eerst).
| Ex-dividend | Betaling | Bedrag / aandeel |
|---|---|---|
| Jul 08, 2025 | — | € 55,00 |
Strategiescores
1 strategy matched
Strategiescores
1 strategy matched
#155 of 172
Recente Activiteit
Ingestapt
Deep Value Investing (Seth Klarman)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"SVA","listing_kind":"stock","pathname":"/stocks/sva","exchange":"NASDAQ","country":"US"}}